We hypothesized that interference with the CCK-BR signaling pathway would shift PSCs to a more quiescent phenotype and reduce their pro-fibrotic and tumor-supportive activity to decrease the growth of pancreatic cancer. This evidence concerns the gene CCK and neoplasm.